In vitro and in vivo evaluation of tumor targeting styrene-maleic acid copolymer-pirarubicin micelles: Survival improvement and inhibition of liver metastases.
about
Synthesis and evaluation of poly(styrene-co-maleic acid) micellar nanocarriers for the delivery of tanespimycin.Styrene maleic acid micelles as a nanocarrier system for oral anticancer drug delivery - dual uptake through enterocytes and M-cells.Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting.Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor.The link between infection and cancer: tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect.Multifunctional nanomicellar systems for delivering anticancer drugs.Clinical applications of spectral molecular imaging: potential and challenges.Polymeric nano-micelles: versatile platform for targeted delivery in cancer.Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls.A Retrospective 30 Years After Discovery of the Enhanced Permeability and Retention Effect of Solid Tumors: Next-Generation Chemotherapeutics and Photodynamic Therapy--Problems, Solutions, and Prospects.Synthesis and therapeutic effect of styrene-maleic acid copolymer-conjugated pirarubicin.Self/co-assembling peptide, EAR8-II, as a potential carrier for a hydrophobic anticancer drug pirarubicin (THP)--characterization and in-vitro deliveryAnalyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs.HPMA Copolymer-Conjugated Pirarubicin in Multimodal Treatment of a Patient with Stage IV Prostate Cancer and Extensive Lung and Bone Metastases.
P2860
Q35375097-D625732F-44B5-4F33-866A-2AD167BD81F9Q35892628-CF046C51-8F32-4910-BCBF-CC677906B05AQ36001530-3F874295-DFE7-4629-A192-4DF5268AF756Q37482536-666DF8F5-9E58-4549-966D-0A5728015E45Q38089750-19A0E0D6-1BBA-456F-9790-BE61BB34B59EQ38119471-59206A2D-9889-4330-B239-DC7A39385C8CQ38182512-CC4AAE04-4BDD-4F33-92D7-82A2943CACBEQ38270690-9BA2AE3D-E0DC-4962-A99F-7FBCCB1103FFQ38271490-32DCA784-8410-4DE5-BAF6-126220247D82Q38559666-E9C51C1F-67A4-4217-A143-3E6B47C76D4AQ38926515-64B3A11D-E862-40D5-90D5-F19E8CFD27ACQ39052370-B21A0BC1-94E1-4F5A-9C56-CC02D24E2096Q51763013-F87B926E-528F-459B-B4DE-27683B3D7198Q53416548-5A8A8424-BF77-4A34-AC06-7B35EC5A4CBE
P2860
In vitro and in vivo evaluation of tumor targeting styrene-maleic acid copolymer-pirarubicin micelles: Survival improvement and inhibition of liver metastases.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
In vitro and in vivo evaluatio ...... nhibition of liver metastases.
@en
In vitro and in vivo evaluatio ...... nhibition of liver metastases.
@nl
type
label
In vitro and in vivo evaluatio ...... nhibition of liver metastases.
@en
In vitro and in vivo evaluatio ...... nhibition of liver metastases.
@nl
prefLabel
In vitro and in vivo evaluatio ...... nhibition of liver metastases.
@en
In vitro and in vivo evaluatio ...... nhibition of liver metastases.
@nl
P2093
P2860
P1433
P1476
In vitro and in vivo evaluatio ...... nhibition of liver metastases.
@en
P2093
Cathy Malcontenti-Wilson
Chris Christophi
Hiroshi Maeda
Jurstine Daruwalla
Khaled Greish
P2860
P304
P356
10.1111/J.1349-7006.2010.01619.X
P577
2010-05-17T00:00:00Z